Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

As Needed Budesonide/Formoterol Combination Versus Regular Budesonide/Formoterol Combination Plus as Needed Terbutaline in Mild-Moderate Persistent Asthma

NCT00849095 is registered in ClinicalTrials.gov with Università degli Studi di Ferrara as lead sponsor.

NCT NCT00849095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00849095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
As Needed Budesonide/Formoterol Combination Versus Regular Budesonide/Formoterol Combination Plus as Needed Terbutaline in Mild-Moderate Persistent Asthma
Lead sponsor
Università degli Studi di Ferrara
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2009
Completion date
May 31, 2013
Enrollment
860 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

asthma